-
Something wrong with this record ?
Aplikační možnosti disoluční metody s průtokovou celou
[Flow-through dissolution method and its application potentials]
Johana Jirásková, Pavel Ondrejček, Tomáš Wolaschka, Milan Řehula, Miloslava Rabišková
Language Czech Country Czech Republic
- Keywords
- in vitro - in vivo,
- MeSH
- Administration, Inhalation MeSH
- Biological Availability MeSH
- Electrochemical Techniques * methods instrumentation utilization MeSH
- Technology, Pharmaceutical standards MeSH
- Drug Evaluation * MeSH
- Dosage Forms standards MeSH
- Drug Delivery Systems * MeSH
- Humans MeSH
- Nanoparticles MeSH
- Prostheses and Implants MeSH
- Reference Books standards MeSH
- Solubility * MeSH
- Stents MeSH
- Check Tag
- Humans MeSH
Flow-through cell dissolution method was implemented in pharmacopoeias in 1990 and since that time its usage significantly increased. It is employed in oral dosage forms with controlled drug release to measure dissolved drug amount within particular time intervals and to characterize pure drug properties (apparent dissolution). Modified flow-through cell is used to determine the drug dissolution from lipophilic dosage forms such as suppositories and soft capsules. Recently, few modifications of this method were published in order to provide drug release studies from parenteral controlled release products and inhalation dosage forms. Review article is presenting last innovations in this area, i.e. new adjustment and arrangement of flow-through cell method, to assess drug release from implants, micro- and nanoparticulate systems, stents and inhalation medicaments in the way more corresponding to in-vivo conditions.
Katedra farmaceutické technologie Farmaceutická fakulta Univerzita Karlova Hradec Králové
Katedra farmaceutickej technológie Univerzita veterinárskeho lekárstva a farmácie Košice
Flow-through dissolution method and its application potentials
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15017274
- 003
- CZ-PrNML
- 005
- 20150608134817.0
- 007
- ta
- 008
- 150515s2015 xr d f 000 0|cze||
- 009
- AR
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a cze $b eng
- 044 __
- $a xr
- 100 1_
- $a Jirásková, Johana $7 _AN081674 $u Katedra farmaceutické technologie, Farmaceutická fakulta, Univerzita Karlova, Hradec Králové
- 245 10
- $a Aplikační možnosti disoluční metody s průtokovou celou / $c Johana Jirásková, Pavel Ondrejček, Tomáš Wolaschka, Milan Řehula, Miloslava Rabišková
- 246 31
- $a Flow-through dissolution method and its application potentials
- 504 __
- $a Literatura
- 520 9_
- $a Flow-through cell dissolution method was implemented in pharmacopoeias in 1990 and since that time its usage significantly increased. It is employed in oral dosage forms with controlled drug release to measure dissolved drug amount within particular time intervals and to characterize pure drug properties (apparent dissolution). Modified flow-through cell is used to determine the drug dissolution from lipophilic dosage forms such as suppositories and soft capsules. Recently, few modifications of this method were published in order to provide drug release studies from parenteral controlled release products and inhalation dosage forms. Review article is presenting last innovations in this area, i.e. new adjustment and arrangement of flow-through cell method, to assess drug release from implants, micro- and nanoparticulate systems, stents and inhalation medicaments in the way more corresponding to in-vivo conditions.
- 650 _2
- $a lékové formy $x normy $7 D004304
- 650 12
- $a lékové transportní systémy $7 D016503
- 650 12
- $a rozpustnost $7 D012995
- 650 _2
- $a biologická dostupnost $7 D001682
- 650 12
- $a hodnocení léčiv $7 D004341
- 650 12
- $a elektrochemické techniky $x metody $x přístrojové vybavení $x využití $7 D055664
- 650 _2
- $a nanočástice $7 D053758
- 650 _2
- $a stenty $7 D015607
- 650 _2
- $a protézy a implantáty $7 D019736
- 650 _2
- $a aplikace inhalační $7 D000280
- 650 _2
- $a farmaceutická technologie $x normy $7 D013678
- 650 _2
- $a referenční knihy $x normy $7 D012013
- 650 _2
- $a lidé $7 D006801
- 653 00
- $a in vitro - in vivo
- 700 1_
- $a Ondrejček, Pavel $7 _AN066608 $u Katedra farmaceutické technologie, Farmaceutická fakulta, Univerzita Karlova, Hradec Králové
- 700 1_
- $a Wolaschka, Tomáš $7 xx0236990 $u Katedra farmaceutickej technológie, Univerzita veterinárskeho lekárstva a farmácie, Košice
- 700 1_
- $a Řehula, Milan, $d 1950-2014 $7 nlk19990074205 $u Katedra farmaceutické technologie, Farmaceutická fakulta, Univerzita Karlova, Hradec Králové
- 700 1_
- $a Rabišková, Miloslava, $d 1951- $7 mzk2005290121 $u Katedra farmaceutické technologie, Farmaceutická fakulta, Univerzita Karlova, Hradec Králové; Katedra farmaceutickej technológie, Univerzita veterinárskeho lekárstva a farmácie, Košice
- 773 0_
- $t Chemické listy $x 0009-2770 $g Roč. 109, č. 1 (2015), s. 34-40 $w MED00011010
- 856 41
- $u http://www.chemicke-listy.cz/ojs3/index.php/chemicke-listy/article/view/411/411 $y domovská stránka časopisu
- 910 __
- $a ABA008 $b B 1918 $c 395 $y 4 $z 0
- 990 __
- $a 20150515132040 $b ABA008
- 991 __
- $a 20150608135202 $b ABA008
- 999 __
- $a ok $b bmc $g 1077466 $s 900194
- BAS __
- $a 3
- BMC __
- $a 2015 $b 109 $c 1 $d 34-40 $i 0009-2770 $m Chemické listy $n Chem. Listy $x MED00011010
- LZP __
- $c NLK137 $d 20150608 $a NLK 2015-19/pk